John Morales
- Healthcare Information
- February 11, 2023
- 3 views
DOJ Signals Increased Scrutiny on Information Sharing
February 10, 2023 Click for PDF On February 2, 2023, DOJ announced the withdrawal of three policy statements concerning healthcare markets[1]: the 1993 Department of Justice and FTC Antitrust Enforcement…
- Medical Treatment
- December 24, 2022
- 3 views
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Summary Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity…
